sufentanil has been researched along with Somatoform Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freye, E; Levy, J | 1 |
1 other study(ies) available for sufentanil and Somatoform Disorders
| Article | Year |
|---|---|
Constitutive opioid receptor activation: a prerequisite mechanism involved in acute opioid withdrawal.
Topics: Acute Disease; Animals; Biotransformation; Dogs; Evoked Potentials, Somatosensory; Naltrexone; Narcotics; Protein Kinase C; Receptors, Opioid; Somatoform Disorders; Substance Withdrawal Syndrome; Sufentanil | 2005 |